Segmentectomy for clinical stage I non–small cell lung cancer: National benchmarks for nodal staging and outcomes by operative approach

Background Segmentectomy is increasingly used for parenchyma sparing anatomical resection for small stage I non–small cell lung cancer (NSCLC). This study characterizes the national outcomes for lymph node assessment and perioperative outcomes of segmentectomy for clinical stage I NSCLC by robotic‐assisted surgery (RATS), video‐assisted thoracoscopic surgery (VATS), and open thoracotomy approach. Methods A retrospective cohort study was conducted of patients who underwent segmentectomy for clinical stage I NSCLC captured in the national Society of Thoracic Surgeons General Thoracic Surgery Database between years 2012 and 2018. Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. Lymph node (LN) staging and 30‐day outcomes were compared by approach. Results A total of 3680 patients (VATS 61.9%, RATS 20%, open 18%) underwent segmentectomy. The IPTW adjusted rate of pathologic LN upstaging (pN1/pN2) was 6.2% (RATS 6.3%, VATS 5.6%, open 8.6%; P = .05). On multivariate analysis, there was no differences in pN1/N2 upstaging between RATS (odds ratio [OR], 0.81; 95% confidence interval [CI], 0.44‐1.49) or VATS (OR, 0.96; 95% CI, 0.57‐1.63) with open segmentectomy. The RATS and VATS approach was associated with fewer postoperative events (RATS 31.3%, VATS 28.8%, open 38.3%; P < .001) and shorter length of stay (RATS 4.3 days, VATS 4.4 days, open 5.2 days; P < .001) as compared with thoracotomy. RATS segmentectomy‐specific complications included a higher rate of pneumothorax after chest tube removal and discharge with chest tube. Major complications were lower after RATS and VATS as compared with open segmentectomy (RATS 5.9%, VATS 4.5%, open 7.2%; P = .028). Conclusions Segmentectomy by VATS and robotic approach resulted in similar high rates of lymph node upstaging as a global marker of the quality of lymph node dissection and were associated with lower overall morbidity and shorter length of stay as compared with open thoracotomy. These national outcomes may serve as benchmarks for future comparative studies. This analysis of segmentectomy procedures for clinical stage I non–small cell lung cancer in the Society of Thoracic Surgery General Thoracic Surgery Database showed similar pathologic lymph node upstaging as a global marker of the quality of lymph node dissection between the robotic, video‐assisted thoracoscopic surgery, and the open thoracotomy approach. Thoracoscopic segmentectomy was associated with fewer compli